TEVA - Teva- Pharmaceutical Industries Ltd. - ADR
Close
18.87
0.140 0.742%
Share volume: 10,069,878
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.73
0.14
0.75%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-10 | 2023-05-10 | 2023-08-02 | 2023-11-09 | 2024-02-12 | 2024-05-08 | 2024-07-31 | |
| Total revenue | 3.595 B | 3.883 B | 3.661 B | 3.878 B | 3.850 B | 4.457 B | 3.819 B | 4.164 B | |
| Cost of revenue | 1.926 B | 2.113 B | 2.079 B | 2.082 B | 1.999 B | 2.040 B | 2.048 B | 2.140 B | |
| Gross profit | 1.669 B | 1.770 B | 1.582 B | 1.796 B | 1.851 B | 2.417 B | 1.771 B | 2.024 B | |
| 6.05% | -10.62% | 13.53% | 3.06% | 30.58% | -26.73% | 14.29% | |||
| Operating expenses | 997.000 M | 1.046 B | 1.076 B | 1.150 B | 1.097 B | 1.128 B | 1.128 B | 1.208 B | |
| Selling general and admin | 822.000 M | 836.000 M | 842.000 M | 910.000 M | 844.000 M | 902.000 M | 886.000 M | 939.000 M | |
| Research and development | 175.000 M | 210.000 M | 234.000 M | 240.000 M | 253.000 M | 226.000 M | 242.000 M | 269.000 M | |
| Total expenses | 2.923 B | 3.159 B | 3.155 B | 3.232 B | 3.096 B | 3.168 B | 3.176 B | 3.348 B | |
| 8.07% | -0.13% | 2.44% | -4.21% | 2.33% | 0.25% | 5.42% | |||
| Operating income | 672.000 M | 724.000 M | 506.000 M | 646.000 M | 754.000 M | 1.289 B | 643.000 M | 816.000 M | |
| Ebit | 672.000 M | 724.000 M | 506.000 M | 647.000 M | 754.000 M | 1.290 B | 639.000 M | 818.000 M | |
| Pretax income | 166.000 M | -1.096 B | -258.000 M | -913.000 M | 76.000 M | 474.000 M | -471.000 M | -245.000 M | |
| -760.24% | -76.46% | 253.88% | -108.32% | 523.68% | -199.37% | -47.98% | |||
| Income tax | 107.000 M | 153.000 M | -19.000 M | -16.000 M | -12.000 M | 40.000 M | -52.000 M | 630.000 M | |
| Net income basic | 56.000 M | -1.219 B | -205.000 M | -863.000 M | 80.000 M | 430.000 M | -139.000 M | -846.000 M | |
| -2,276.79% | 83.18% | -320.98% | 109.27% | 437.50% | -132.33% | -508.63% | |||
| Net income | 56.000 M | -1.219 B | -205.000 M | -863.000 M | 80.000 M | 430.000 M | -139.000 M | -846.000 M | |
| -2,276.79% | 83.18% | -320.98% | 109.27% | 437.50% | -132.33% | -508.63% |